SNHG3 and pachyonychia congenita: Research using the Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD) database revealed higher SNHG3 expression in prostate cancer patients with bone metastasis (PC/BM) compared to non-metastatic cases (PC/nBM) [32].